top of page

Morten Sogaard

President and Division Head, Gene Therapy Research and Technical Operations at Astellas Gene Therapy

Morten is responsible for advancing the company’s pipeline from discovery through to IND-enabling preclinical development including Discovery Biosciences, Integrative Biology, Strategy & Project Management, non-GMP CMC (Tech Development), Research Engineering and Facilities. Morten also is overseeing gene therapy technology and early stage partnerships.

Prior to joining Astellas Gene Therapies in May 2022, Morten was Head of Target Sciences at Pfizer and served as a member of the global R&D Leadership Team. Morten also held various leadership roles at Pfizer in Diagnostics, Genomics, Genetics and Computational Capabilities, as well as External R&D for Platform Technologies and Oncology.
Prior to Pfizer, Morten led Immuno-Oncology research at Pharmacia, headed the Global Enabling Technologies and Research Informatics at Boehringer Ingelheim, and oversaw Molecular Sciences research at AstraZeneca.

Morten has a Ph.D. in Biochemistry with a focus on protein engineering from the University of Copenhagen.

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
STORIES
MEETINGS
MEMBERS
Speakers
bottom of page